Michael Hadjiloucas is Partner-in-Charge of the firm’s Corporate Tax Group, and National Pharmaceutical and Medical Devices Sector Leader, within the Technology and Life Sciences Group. With nearly 30 years of experience, his expertise includes both domestic and international corporate taxation, acquisitions, reorganization with both publicly traded and private companies.
Michael has extensive experience with corporate, partnership, individual and tax-exempt entity tax returns and representation at Federal and state audits. In addition, he is one of the firm’s experts in tax provisions and uncertain tax positions (ASC 740). He advises the firm’s tax and audit clients with all tax matters including, tax provisions mergers, stock options, research and development tax credits, transfer pricing and state tax matters.
Since joining the firm in 2005, Michael has been responsible for the firm’s major domestic and international publicly traded and private clients (with some in billions of sales) within the manufacturing and service industries, including pharmaceuticals, medical devices, life science, technology, telecom, distribution and retail.
Prior to joining the firm, Michael was with a Big 4 accounting firm for 10 years.
In the community, Michael is an active board member of Association for Corporate Growth (ACG) and involved with BioNJ. He is also part of the board of various Hellenic organizations and served as Chairman of Greek American Chamber and Vice President of Cyprus US Chamber.